| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.31 | 0.02 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.02 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.096 | 0.02 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.14 | 0.02 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.02 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |